Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CYP4F3 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
mRNA | ATP8B4 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
mRNA | WDR41 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |
mRNA | ICE2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
mRNA | ANKS1B | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
mRNA | AC026449.1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
mRNA | RTKN | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |
mRNA | UBR3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
mRNA | NTHL1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
mRNA | COL13A1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |